Benchmark Holdings Shows Resilience in Q4 FY24 Despite Industry Challenges

Benchmark Holdings ( (GB:BMK) ) has shared an announcement.

Benchmark Holdings reported resilient Q4 FY24 financial results amidst challenging conditions, particularly in the Advanced Nutrition and Genetics sectors. The company recorded total revenues of £36.8 million, a slight increase over the previous year, attributed to strong performance in Advanced Nutrition despite challenging global shrimp markets. The Genetics business, held for disposal, also showed steady results. However, revenues in the Health sector decreased due to a pause in Ectosan® Vet and CleanTreat® activities. Benchmark has maintained financial discipline, reducing operating costs by 35% compared to the prior year, and has positioned itself for future growth with ongoing efforts to streamline its structure and improve profitability.

More about Benchmark Holdings

Benchmark Holdings is a leading aquaculture biotechnology company focused on driving sustainability in the industry by providing products and solutions that enhance yield, growth, and animal health and welfare. With a global presence in 25 countries, Benchmark serves major aquaculture markets worldwide.

YTD Price Performance: -1.03%

Average Trading Volume: 117,219

Technical Sentiment Consensus Rating: Buy

Current Market Cap: £249.3M

See more insights into BMK stock on TipRanks’ Stock Analysis page.